Page last updated: 2024-10-30

losartan and Cancer Pain

losartan has been researched along with Cancer Pain in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.

Research Excerpts

ExcerptRelevanceReference
" Spontaneous and evoked pain behaviors were assessed before and after acute and chronic administration of Ang-(1-7)."1.43Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain. ( Arnold, MR; Forte, BL; Hay, M; Largent-Milnes, TM; Slosky, LM; Staatz, WD; Vanderah, TW; Zhang, H, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Forte, BL1
Slosky, LM1
Zhang, H1
Arnold, MR1
Staatz, WD1
Hay, M1
Largent-Milnes, TM1
Vanderah, TW1

Other Studies

1 other study available for losartan and Cancer Pain

ArticleYear
Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
    Pain, 2016, Volume: 157, Issue:12

    Topics: Analgesics; Analysis of Variance; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensi

2016